Bruising or bleeding after a GLP‑1 shot: what to expect
A small blood spot or bruise can happen after an injection. Learn what to do and which signs need medical attention.
Read More →GLP‑1 and loose skin after weight loss: why it happens and what helps
Loose skin after GLP‑1 weight loss is common. Learn why it happens and what strategies can help support skin firmness.
Read More →Is compounded semaglutide safe: what you need to know
Compounded semaglutide is not FDA-approved. Learn about dosing errors, storage risks, current FDA guidance, and questions to ask your prescriber and pharmacist.
Read More →Best exercises while on GLP‑1 medications: what to do and when
Many GLP‑1 users actually decrease physical activity after starting medication. Here is why exercise matters more, not less, on these drugs and what types deliver the best results.
Read More →GLP‑1 dose schedules explained: titration, maintenance, and what to expect at each level
Compare current labeled starting, escalation, and maintenance doses for injectable and oral GLP‑1 medications, plus when to call your prescriber.
Read More →How to switch between GLP‑1 medications safely
Switching GLP‑1 medications requires a prescriber-guided start date and dose. Learn why there is no universal conversion or washout rule and what to track during a transition.
Read More →Lump after a GLP‑1 injection: what to check and when to get help
Talk to your healthcare provider about any lump after a GLP‑1 injection. Learn what to record, which warning signs need care, and how to choose your next site.
Read More →GLP‑1 medications and fertility: pregnancy and contraception
Understand the evidence on GLP‑1 medications and fertility, tirzepatide birth-control precautions, and how to plan treatment around pregnancy with your clinician.
Read More →GLP‑1 and menstrual changes: what the evidence says
Evidence on GLP‑1 medicines and menstrual changes remains limited. See tirzepatide's oral birth control warning, pregnancy guidance, and when to contact your clinician.
Read More →What happens when you stop taking a GLP‑1 medication: the data on weight regain
Research consistently shows that most people regain approximately two-thirds of lost weight within a year of stopping a GLP‑1 medication. Here is what the data says, why it happens, and how to prepare.
Read More →GLP‑1 and constipation: why it happens and how to find relief
Constipation can occur on semaglutide or tirzepatide. Learn what trials show, which relief options to discuss, and when to seek medical care.
Read More →Ozempic vs Wegovy vs Mounjaro vs Zepbound: how to compare GLP‑1 medications
Compare Ozempic, Wegovy, Mounjaro, and Zepbound by approved uses, doses, formulations, trial results, and side effects. Updated for current U.S. prescribing information.
Read More →Best foods to eat and limit on GLP‑1 medications
Build meals with protein, fiber, and foods you tolerate on semaglutide or tirzepatide. Learn what may worsen nausea and when to ask for nutrition support.
Read More →What to expect in your first month on a GLP‑1: a week-by-week guide
Starting semaglutide or tirzepatide comes with changes your body needs time to adjust to. Here is what to expect each week and when something needs medical attention.
Read More →Medication leaked after your GLP‑1 injection: what to check
A drop and a larger leak need different checks. Review device-specific completion signals and get advice before taking extra GLP‑1 medication.
Read More →How long should you stay on GLP‑1 medications?
Read the evidence on long-term GLP‑1 treatment, weight regain after stopping, and the questions to discuss with your prescriber before changing your plan.
Read More →